Trader Note — 9238 total
Hippo Holdings heads into its July 30 earnings date with options positioning near its most bullish extreme of the past year, even as insiders have been quietly trimming throughout the quarter. The options signal is the…
Core & Main heads into the week as one of the cleaner stories in its sector right now — a stock down sharply from its highs, a Street that still sees meaningful upside, and a lending market with no pressure…
GXO Logistics heads into its August earnings window with a notable disconnect: the Street is turning more constructive, yet short positions have climbed nearly a quarter in a month. The analyst story is the most…
T1 Energy heads into earnings season with a stock in freefall, a major strategic shareholder cutting its position, and short sellers sitting on nearly a quarter of the free float. The week's defining move was brutal.…
RIVN enters its July 28 earnings window under genuine pressure, with Tuesday's 18% single-session collapse dragging the stock to $16.49 and reigniting a bear thesis that shorts have been steadily rebuilding all…
Ryan Specialty Holdings has gained 10% in a single week, and the Street scrambled to keep up — making this the most analyst-active week the stock has seen in months. The pace of target revisions tells the story…
DT Midstream enters the final stretch before its July 31 Q2 results with a fresh analyst endorsement and options traders showing unusually little demand for downside protection. JP Morgan's Jeremy Tonet raised his…
Vera Therapeutics enters the second week of July with a striking split: five analysts raised price targets on the same day the stock jumped 7%, yet short sellers are sitting on nearly 19% of the float with no sign of…
Seagate Technology Holdings enters the final stretch before its July 23 earnings print having surrendered 14% in a week — yet with the analyst community refusing to blink. The price action is the story this week. STX…
DigitalOcean enters the final stretch before its August 4 earnings report with a notable divergence: short sellers are quietly unwinding while institutional money flows in — yet the stock has shed nearly 20% in a…
Leonardo DRS enters its July 30 earnings window with shorts steadily unwinding, options traders leaning constructively, and the Street's analyst community holding a largely positive view — the tension worth watching is…
Coinbase Global finds itself in a curious position this week: the stock has bounced hard while short sellers have quietly trimmed exposure — yet options traders remain more defensive than usual, and the Street's price…
Valaris heads into its July 30 earnings with a fresh analyst cut landing on a stock that has lost 16% in a month, yet short sellers appear to be quietly covering rather than pressing the trade. The most significant…
Hims & Hers Health heads into the week before its August 3 earnings with the short position still enormous but the acute squeeze pressure of late June clearly unwinding. The lending market has shifted meaningfully…
AFRM heads into the week after a strong month with an unusual dynamic: the analyst community is moving more constructively just as short sellers trim exposure, yet options traders are edging more defensive — leaving…
RGC enters the week with its lending pool nearly exhausted — a condition that has persisted for days and is now intensifying as short interest accelerates sharply higher. The borrow story is the dominant angle here.…
PROG Holdings enters the final stretch before its July 29 earnings report with the Street sharply divided — and a fresh, high-conviction analyst upgrade arriving just as the stock pulls back from its recent highs. The…
MediaAlpha enters the week after a 50% one-month surge with an unusual split: the Street just turned more bullish, insiders are using the run-up to sell, and options traders are the least defensive they have been all…
OPEN enters the second week of July with its bear camp dug in — short interest has barely moved from the multi-month high set last week, the CEO is buying into the weakness, and earnings are five weeks away. The short…
Immunome heads into the week with a striking split: the stock is up 15% in five days, but insiders are selling into every uptick while short sellers are holding their ground. The insider activity tells the most urgent…
